News, Updates and Press Releases

April 13, 2021

Sona Secures Clinical Trial Authorization and Hospital Partner

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated April 9, 2021...

Read more

April 12, 2021

Sona Establishes an At-the-Market Common Share Offering

Halifax, Nova Scotia—(Newsfile Corp. – April 9, 2021) –Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona“) a...

Read more

March 23, 2021

Sona Announces Filing of Preliminary Short Form Base Shelf Prospectus

March 23, 2021 – Halifax, Nova Scotia – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company” or “Sona“) a...

Read more

December 31, 2020

Sona Nanotech Receives CE Mark Approval for its Rapid COVID-19 Antigen Test

December 31, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”, “Sona”) a developer of...

Read more

December 16, 2020

Sona Nanotech Closes Unbrokered Private Placement Financing for $2.26m in Gross Proceeds

December 16, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”, “Sona”) a developer of...

Read more

December 10, 2020

Sona Nanotech Comments on Market Activity

December 10, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”, “Sona”) a developer of...

Read more

December 8, 2020

Sona Nanotech $2m Private Placement Financing Fully Subscribed

December 3, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”, “Sona”) a developer of...

Read more

December 3, 2020

Sona Nanotech Arranges Private Placement Financing and Appoints EU Agent for Application for CE Mark

December 3, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”, “Sona”) a developer of...

Read more

November 30, 2020

Sona Nanotech Provides Corporate Update

November 30, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”), a developer of rapid,...

Read more

November 25, 2020

Sona Nanotech Withdraws Rapid COVID-19 Antigen Test Application Based on Feedback from Health Canada

November 25, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”), a developer of rapid,...

Read more

November 4, 2020

Sona Nanotech appoints new Director

November 3, 2020 – Halifax, Canada – Sona Nanotech Inc. (CSE: SONA) (the “Company”) is pleased to announce the appointment...

Read more

October 29, 2020

Sona Nanotech Receives ‘Deprioritization’ from FDA; Health Canada Evaluation Continues

October 29, 2020 - Halifax, Canada – Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the “Company”), a developer of rapid, point-of-care diagnostic tests, ...

Read more